Fluvoxamine, an antidepressant, is one of four FDA-approved repurposed medications tested in ACTIV-6, a nationwide remote study.

Faculty members are exploring the use of ChatGPT in student learning environments, and their own personal research.

Once a rising star in Uruguayan field hockey, a Duke neuropsychologist now tackles disparities, aiming to reshape how the nation's largest, fastest-growing minority group receives Alzheimer’s and dementia care.

Physician Assistant (PA) Micaela Marker was looking for somewhere to donate her time when she saw an article in the Denver Post about a nonprofit organization called Global Care Force that was looking for volunteers for medical trips to Ukraine.

Co-authors Eric Elbogen, PhD, professor of psychiatry and behavioral sciences, and Nico Verykoukis, a retired clinical social worker with 29 years of experience, debunk the common myth that most perpetrators of violent crime are mentally ill.

A study in twins found that even a single traumatic brain injury at any age was associated with worse cognitive function in later life, independent of genes and environmental factors.

CTSI has launched the Center for Precision Health (CPH), a collaboration led by Svati Shah that will harness the power of genomic, biomarker, and health data to transform patient care and population health.

Mary Klotman, MD, talks with faculty member Leonor Corsino, MD, MHS, about improving health access and care in underrepresented populations.

The Office of Biomedical Graduation Education honored exceptional second-year international PhD students with nine prestigious International Chancellor’s Scholarships.

Speaking to media in a virtual briefing, infectious disease specialist Dr. Cameron Wolfe and David Montefiori, Ph.D., director of the Duke Human Vaccine Institute, said booster shots continue to be effective for those Americans who routinely get them.